Table 6.
Study Code | Age, Sex, Disease | TNF-α Blocker Treatment |
Antifungal Treatment |
IRIS Manifestation | Culture, Urine Antigen | Treatment Modification | Outcome | ||
---|---|---|---|---|---|---|---|---|---|
Drug | Time From Discontinuation to Onset of IRIS | Drug | Duration Prior to Onset of IRIS | ||||||
1a | 66 F Sarcoidosis | Infliximab | 10 wk | AMB deoxycholate | 7 d | ARDS, reticulonodular infiltrates evolving to bilateral consolidation | 8.48 U at diagnosis 4.39 U at IRIS |
Corticosteroid | Recovered after 40 d hospitalization |
2a | 47 M Rheumatoid arthritis | Adalimumab | 6 wk | Voriconazole | 33 d | Worsening liver function tests | 5.55 U at diagnosis 1.77 U at IRIS |
Voriconazole changed to fluconazole | Recovered |
4a | 9 F Juvenile rheumatoid arthritis | Etanercept | 1 wk | Liposomal AMB | 4 d | Worsening respiratory failure | 5.08 ng/mL at diagnosis <0.6 ng/mL at IRIS |
None | Recovered |
10a | 50 M Rheumatoid arthritis | Infliximab | 4 wk | AMB deoxycholate | 7 d | ARDS, reticulonodular infiltrates evolving to bilateral consolidation | BAL culture positive at presentation Undetectable at IRIS |
None | Recovered after 6 wk of mechanical ventilation |
11a | 62 M Crohn disease | Infliximab | 10 wk | AMB | 1 d | ARDS, reactive hemophagocytic syndrome | BAL and bone marrow culture positive | Corticosteroid | Recovered after 12 d of mechanical ventilation and 40 d hospitalization |
12a | 46 F Crohn disease | Infliximab | 9 wk | Itraconazole | 0 | Enlarging lung mass and hilar lymphadenopathy | FNA of lymph node showed reactive inflammation, Ag 4.6 U | None | Recovered |
14a | 20 F Crohn disease | Infliximab | 6 wk | Itraconazole | 6 d | ARDS, reticulonodular infiltrates evolving to bilateral consolidation | 5.72 ng/mL at diagnosis, 5.21 ng/mL at IRIS | Itraconazole changed to AMB | Recovered after 1 wk mechanical ventilation and 20 d hospitalization |
19a | 29 F Crohn disease | Adalimumab | 4 wk | Itraconazole | 12 d | New low-density splenic lesions, hilar lymphadenopathy and pulmonary nodules | 10.3 ng/mL at diagnosis, 4.29 ng/mL at IRIS | None | Recovered |
20 | 58 F Rheumatoid arthritis | Etanercept | 45 wk | Itraconazole | 45 wk | Left supraclavicular lymphadenopathy with biopsy showing granulomatous inflammation and fungal elements | 8.46 ng/mL at diagnosis, undetectable at IRIS. Tissue culture no growth | Continued etanercept, prednisone, itraconazole | Recovered |
Abbreviations: Ag, antigen; AMB, amphotericin B; ARDS, acute respiratory distress syndrome; BAL, bronchoalveolar lavage fluid; FNA, fine needle aspiration; IRIS, immune reconstitution inflammatory syndrome; TNF, tumor necrosis factor.
a Previously published [8].